Fig. 13From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationHaemolysis by nanoformulations of VC-loaded in TCs-HA and pure VC as compared to positive 623 (Triton-X-100) and negative control (PBS) in pure blood taken from healthy volunteers, n = 3, mean ± SD, p ≤ 0.05Back to article page